Chronic Kidney DiseaseKidney DiseaseLabMedia ReleasesMolecular Endocrinology and PharmacologyNews & EventsResearchResearch Area
Phase 3 drug trial for rare chronic kidney disease achieves key milestone
By Richard Schoonraad | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research AreaBiopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…
Molecular Endocrinology and PharmacologyMolecular MedicineNews & Events
Double hit of new appointments for Head of Molecular Endocrinology and Pharmacology
By Alicia Bienkowski | Molecular Endocrinology and Pharmacology, Molecular Medicine, News & EventsPerkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) earlier this month. Coincidentally, on…
Chronic Kidney DiseaseFundingKidney DiseaseKidneysMedia ReleasesMolecular Endocrinology and PharmacologyMolecular MedicineNews & EventsResearch Area
$20M for biopharm DIMERIX to fund phase 3 trials for rare kidney disease
By Alicia Bienkowski | Chronic Kidney Disease, Funding, Kidney Disease, Kidneys, Media Releases, Molecular Endocrinology and Pharmacology, Molecular Medicine, News & Events, Research AreaBiopharmaceutical company, Dimerix (ASX: DXB), which is developing new treatments for types of inflammatory kidney and respiratory diseases, announced it has successfully raised $20 million to fund Phase 3 trials…
Epigenetics and Genomics LaboratoryMedia ReleasesMolecular Endocrinology and PharmacologyNews & Events
Dual win sees two Harry Perkins researchers awarded in 2020 Business Events Perth Aspire Awards
By Alicia Bienkowski | Epigenetics and Genomics Laboratory, Media Releases, Molecular Endocrinology and Pharmacology, News & EventsBusiness Events Perth, in partnership with the Harry Perkins Institute of Medical Research, is pleased to announce that the inaugural Harry Perkins Aspire Award has been presented to two applicants:…
LabMolecular Endocrinology and PharmacologyNews & EventsResearch
Australian drug chosen for global trial to treat COVID-19
By Alicia Bienkowski | Lab, Molecular Endocrinology and Pharmacology, News & Events, ResearchA drug developed by Perkins and UWA spinout company Dimerix will be used in a global trial to treat patients who have Acute Respiratory Distress Syndrome (ARDS) as a result…
CancerChronic Kidney DiseaseDisease AreaLabMolecular Endocrinology and PharmacologyMolecular MedicineNews & EventsResearchResearch Area
New way to examine how medicines act on cells
By Marlin Communications | Cancer, Chronic Kidney Disease, Disease Area, Lab, Molecular Endocrinology and Pharmacology, Molecular Medicine, News & Events, Research, Research AreaUsing a genome editing technique called CRISPR/Cas9, the researchers attached a super-bright glowing molecule, derived from deep sea shrimp, to specific molecules important for signalling in cancer cells, ‘receptors’. Receptors…
